Form 4 for XYL Xylem Inc.
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-19 · accession 0001209191-21-047358 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-20 | 2021-07-19 | XYL | Sabol Colin R | SVP | M - OptEx | $48.33 | +3,800 | 31.0K | +14% | +$183.7K |
| DM | 2021-07-20 | 2021-07-19 | XYL | Sabol Colin R | SVP | S - Sale+OE | $117.29 | -5,595 | 29.1K | -16% | -$656.2K |
| DM | 2021-07-20 | 2021-07-19 | XYL | Sabol Colin R | SVP | M - OptEx | $0.00 | -3,800 | 11.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-19 | M | A | 1,900 | $48.33 | 30,975 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-19 | S | D | 205 | $117.90 | 27,280 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F3) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 3 | Common | Common Stock | 2021-07-19 | S | D | 1,590 | $116.91 | 27,485 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F4) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,390 Shares were executed at a range of prices from $116.28 to $117.25. 200 Shares were executed at a range of prices from $117.34 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 4 | Common | Common Stock | 2021-07-19 | S | D | 1,900 | $117.90 | 29,075 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F3) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 5 | Common | Common Stock | 2021-07-19 | M | A | 1,900 | $48.33 | 30,975 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-19 | S | D | 1,900 | $116.92 | 29,075 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 Shares were executed at a range of prices from $116.31 to $117.27. 300 Shares were executed at a range of prices from $117.33 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-07-19 | M | D | 1,900 | $0.00 | 13,306 | D | $48.33 · — to 2027-02-21 | 1,900 Common | (F5) These options are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-07-19 | M | D | 1,900 | $0.00 | 11,406 | D | $48.33 · — to 2027-02-21 | 1,900 Common | (F5) These options are fully vested and exercisable. |